Pub Date : 2024-07-25DOI: 10.12775/qs.2024.18.53301
Julia Kuszneruk, Katarzyna Chawrylak, Magdalena Kłusek, Maria Kubas, Katarzyna Krzemińska
Introduction and purposes: Degenerative diseases of the nervous system, such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS). Environmental influences are significant contributors to the development of these conditions. The primary objective of this research was to examine key environmental factors that are suspected of their impact on the development of diseases, specifically lifestyle, medical conditions, diet and exposure to environmental pollution. Materials and Methods: A systematic literature search was conducted using PubMed and Google Scholar. The search employed terms such as 'Alzheimer's disease,' 'Parkinson disease,' 'amyotrophic lateral sclerosis,' 'environment,' 'pollution,' 'diet,' 'traumatic brain injury,' 'alcohol,' 'obesity,' 'lifestyle factors'. The search included articles published from 2014 to 2024. Results: Among environmental factors with regard to lifestyle choices, a healthy diet has a protective effect against these diseases, while alcohol consumption was not clearly categorised as harmful or protective. Among past illnesses, an increase in AD, PD after head injury was confirmed, but more research is required as to the impact on ALS incidence. Lipid metabolism disorders affect ALS morbidity, for the AD and PD, studies do not reach consensus. Similarly, with regard to body weight, studies do not clearly indicate whether it is relevant. On the contrary, when it comes to pollution, a lot of studies showed a correlation. Conclusion: In summary, research studies varied in size and quality, so caution must be exercised in drawing conclusions. This review suggests that there is a relationship with the environment, and future research may focus on exploring these connections.
导言和目的：神经系统退行性疾病，如阿尔茨海默病（AD）、帕金森病（PD）和肌萎缩侧索硬化症（ALS）。环境影响是导致这些疾病发生的重要因素。本研究的主要目的是研究疑似影响疾病发展的关键环境因素，特别是生活方式、医疗条件、饮食和环境污染暴露。材料和方法：使用 PubMed 和 Google Scholar 进行了系统的文献检索。搜索使用的术语包括 "阿尔茨海默病"、"帕金森病"、"肌萎缩侧索硬化症"、"环境"、"污染"、"饮食"、"脑外伤"、"酒精"、"肥胖"、"生活方式因素"。检索包括 2014 年至 2024 年发表的文章。搜索结果在与生活方式选择有关的环境因素中，健康饮食对这些疾病具有保护作用，而饮酒则没有被明确划分为有害或保护作用。在既往疾病中，已证实头部受伤后注意力缺失症和注意力缺失性痴呆症的发病率有所上升，但对肌萎缩性脊髓侧索硬化症发病率的影响还需要更多研究。脂质代谢紊乱会影响 ALS 的发病率，但对于注意力缺失症和注意力缺失综合症，研究并未达成共识。同样，关于体重，研究也没有明确指出其是否相关。相反，在污染方面，很多研究都显示存在相关性。结论总之，研究的规模和质量参差不齐，因此在得出结论时必须谨慎。本综述表明，与环境之间存在着一定的关系，未来的研究可能会侧重于探索这些联系。
{"title":"What role do environmental factors play in the development of neurodegenerative diseases? A narrative review","authors":"Julia Kuszneruk, Katarzyna Chawrylak, Magdalena Kłusek, Maria Kubas, Katarzyna Krzemińska","doi":"10.12775/qs.2024.18.53301","DOIUrl":"https://doi.org/10.12775/qs.2024.18.53301","url":null,"abstract":"Introduction and purposes: Degenerative diseases of the nervous system, such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS). Environmental influences are significant contributors to the development of these conditions. The primary objective of this research was to examine key environmental factors that are suspected of their impact on the development of diseases, specifically lifestyle, medical conditions, diet and exposure to environmental pollution.\u0000 \u0000Materials and Methods: A systematic literature search was conducted using PubMed and Google Scholar. The search employed terms such as 'Alzheimer's disease,' 'Parkinson disease,' 'amyotrophic lateral sclerosis,' 'environment,' 'pollution,' 'diet,' 'traumatic brain injury,' 'alcohol,' 'obesity,' 'lifestyle factors'. The search included articles published from 2014 to 2024.\u0000 \u0000Results: Among environmental factors with regard to lifestyle choices, a healthy diet has a protective effect against these diseases, while alcohol consumption was not clearly categorised as harmful or protective. Among past illnesses, an increase in AD, PD after head injury was confirmed, but more research is required as to the impact on ALS incidence. Lipid metabolism disorders affect ALS morbidity, for the AD and PD, studies do not reach consensus. Similarly, with regard to body weight, studies do not clearly indicate whether it is relevant. On the contrary, when it comes to pollution, a lot of studies showed a correlation.\u0000 \u0000Conclusion: In summary, research studies varied in size and quality, so caution must be exercised in drawing conclusions. This review suggests that there is a relationship with the environment, and future research may focus on exploring these connections.\u0000 ","PeriodicalId":431915,"journal":{"name":"Quality in Sport","volume":"12 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141802884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-25DOI: 10.12775/qs.2024.18.53281
Aneta Jerzak, Katarzyna Jakubowska, Aleksandra Janocha, Paweł Ziemba
Introduction and purpose Bruxism is a stereotypical motor disorder characterized by involuntary grinding or clenching of the teeth during sleep or wakefulness. Bruxism affects 5-50% of children, and its frequency decreases with age. Bruxism is the most commonly occurring parasomnia, which in healthy individuals is a variant of physiology; however, when it leads to the development of associated pathologies such as dental abrasions, tooth loss, toothaches, headaches, or temporomandibular disorders, it is an indication for treatment. Materials and methods The literature included in the PubMed databases is searched through the words such as bruxism, temporomandibular disorder. Description of the state of knowledge In the diagnosis of bruxism, questionnaires filled out by patients and parents of children are most commonly used, although the most effective but less accessible diagnostic test is polysomnography. In the treatment of bruxism, pharmacotherapy, occlusal splints, and physiotherapy are used. Conclusions There is no gold standard for treating bruxism. There is still a need to search for other methods that would eliminate bruxism and prevent the development of associated pathologies.
{"title":"When and How to treat bruxism in children? - A review of the latest literature","authors":"Aneta Jerzak, Katarzyna Jakubowska, Aleksandra Janocha, Paweł Ziemba","doi":"10.12775/qs.2024.18.53281","DOIUrl":"https://doi.org/10.12775/qs.2024.18.53281","url":null,"abstract":"Introduction and purpose \u0000Bruxism is a stereotypical motor disorder characterized by involuntary grinding or clenching of the teeth during sleep or wakefulness. Bruxism affects 5-50% of children, and its frequency decreases with age. Bruxism is the most commonly occurring parasomnia, which in healthy individuals is a variant of physiology; however, when it leads to the development of associated pathologies such as dental abrasions, tooth loss, toothaches, headaches, or temporomandibular disorders, it is an indication for treatment. \u0000Materials and methods \u0000The literature included in the PubMed databases is searched through the words such as bruxism, temporomandibular disorder. \u0000Description of the state of knowledge \u0000In the diagnosis of bruxism, questionnaires filled out by patients and parents of children are most commonly used, although the most effective but less accessible diagnostic test is polysomnography. In the treatment of bruxism, pharmacotherapy, occlusal splints, and physiotherapy are used. \u0000Conclusions \u0000There is no gold standard for treating bruxism. There is still a need to search for other methods that would eliminate bruxism and prevent the development of associated pathologies.","PeriodicalId":431915,"journal":{"name":"Quality in Sport","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141803496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-25DOI: 10.12775/qs.2024.18.53211
Karol Bochyński, Michał Dacka, Kamila Giżewska, Konrad Białogłowski, Paulina Dąbrowska, Michał Żuber, Katarzyna Ciuba, Katarzyna Molenda, Filip Borodziuk, Barbara Borodziuk
Introduction and Purpose Hashimoto’s disease is the most common reason of hypothyroidism. Usually, it is easy to recognize and treat. However, under certain circumstances, it may develop into the most severe manifestation of hypothyroidism known as myxedema and can lead to a threat to the patient's life. Hypothyroid crisis, or myxedema coma, is an extremely rare but fatal medical emergency. If the condition is not promptly diagnosed and treated, the mortality rate is high as 50%. Even with immediate recognition and appropriate medical intervention, mortality rates of up to 25% have been observed. This article aim is to enhance medical community awareness by examining features of myxedema, prevalence, and associated risk factors, contributing to improved clinical management. Emphasizing tailored treatment strategies for hypothyroidism, coexisting illnesses, and metabolic decompensation, it ultimately seeks to enhance outcomes for patients with severe hypothyroidism. Material and methods Conducting a systematic review of medical articles from 1997 to 2024 using PubMed, this study analyzed articles with keywords such myxedema coma, hypothyroidism, Hashimoto’s thyroiditis. Inclusion of pertinent articles ensured a comprehensive exploration of myxedema coma literature during the specified time frame. Summary Myxedema coma is a thyroid emergency linked to hypothyroidism. This review sheds light on the etiology of myxedema, clinical manifestations, diagnostic criteria and comprehensive treatment options. In order to reduce mortality in patients, there is a need to increase knowledge of the risk of development, clinical features and management not only for emergency physicians but also for physicians of all specialties..
{"title":"Can one die because of Hashimoto’s disease? – a clinical review of diagnosis, clinical features and treatment of myxedema coma","authors":"Karol Bochyński, Michał Dacka, Kamila Giżewska, Konrad Białogłowski, Paulina Dąbrowska, Michał Żuber, Katarzyna Ciuba, Katarzyna Molenda, Filip Borodziuk, Barbara Borodziuk","doi":"10.12775/qs.2024.18.53211","DOIUrl":"https://doi.org/10.12775/qs.2024.18.53211","url":null,"abstract":"Introduction and Purpose \u0000Hashimoto’s disease is the most common reason of hypothyroidism. Usually, it is easy to recognize and treat. However, under certain circumstances, it may develop into the most severe manifestation of hypothyroidism known as myxedema and can lead to a threat to the patient's life. \u0000Hypothyroid crisis, or myxedema coma, is an extremely rare but fatal medical emergency. If the condition is not promptly diagnosed and treated, the mortality rate is high as 50%. Even with immediate recognition and appropriate medical intervention, mortality rates of up to 25% have been observed. \u0000This article aim is to enhance medical community awareness by examining features of myxedema, prevalence, and associated risk factors, contributing to improved clinical management. Emphasizing tailored treatment strategies for hypothyroidism, coexisting illnesses, and metabolic decompensation, it ultimately seeks to enhance outcomes for patients with severe hypothyroidism. \u0000Material and methods \u0000Conducting a systematic review of medical articles from 1997 to 2024 using PubMed, this study analyzed articles with keywords such myxedema coma, hypothyroidism, Hashimoto’s thyroiditis. Inclusion of pertinent articles ensured a comprehensive exploration of myxedema coma literature during the specified time frame. \u0000Summary \u0000Myxedema coma is a thyroid emergency linked to hypothyroidism. This review sheds light on the etiology of myxedema, clinical manifestations, diagnostic criteria and comprehensive treatment options. In order to reduce mortality in patients, there is a need to increase knowledge of the risk of development, clinical features and management not only for emergency physicians but also for physicians of all specialties..","PeriodicalId":431915,"journal":{"name":"Quality in Sport","volume":"104 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141802452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are autoimmune diseases that frequently coexist, complicating clinical management due to the compounded risks of systemic inflammation and thromboembolism. We present a case of a 52-year-old female with SLE and APS, initially diagnosed after a pulmonary embolism in 2015. Her medical history includes recurrent anemia, hyperlipidemia, hypertension, and two myocardial infarctions treated with angioplasty and stenting. Despite treatment with hydroxychloroquine, methylprednisolone, methotrexate and apixaban (later switched to warfarin), the patient experienced severe disease flare-ups and cardiovascular complications, prompting consideration for biologic therapy with anifrolumab. This case study illustrates the difficulties associated with the management of concurrent SLE and APS. It is clear that early diagnosis, vigilant monitoring, and aggressive management of both autoimmune and cardiovascular risks are essential to improve patient outcomes.
{"title":"Severe case of antiphospholipid syndrome coexisting with systemic lupus erythematosus with major cardiovascular complications: a case report","authors":"Wiktoria Bińczyk, Bartosz Siudek, Olrgierd Dróżdż, Patrycja Brzozowska, Bianka Nowińska, Karina Lissak, Renata Sokolik","doi":"10.12775/qs.2024.18.52945","DOIUrl":"https://doi.org/10.12775/qs.2024.18.52945","url":null,"abstract":"Systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are autoimmune diseases that frequently coexist, complicating clinical management due to the compounded risks of systemic inflammation and thromboembolism. We present a case of a 52-year-old female with SLE and APS, initially diagnosed after a pulmonary embolism in 2015. Her medical history includes recurrent anemia, hyperlipidemia, hypertension, and two myocardial infarctions treated with angioplasty and stenting. Despite treatment with hydroxychloroquine, methylprednisolone, methotrexate and apixaban (later switched to warfarin), the patient experienced severe disease flare-ups and cardiovascular complications, prompting consideration for biologic therapy with anifrolumab. This case study illustrates the difficulties associated with the management of concurrent SLE and APS. It is clear that early diagnosis, vigilant monitoring, and aggressive management of both autoimmune and cardiovascular risks are essential to improve patient outcomes.","PeriodicalId":431915,"journal":{"name":"Quality in Sport","volume":"95 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141802474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-25DOI: 10.12775/qs.2024.18.52161
Agata Magierska, Z. Szczepaniak, Olga Ptak, Krzysztof Gomułka
Introduction: The widespread prevalence of chronic rhinitis necessitates the search for effective treatment methods. Modern type of medicine is biological treatment. Pathomechanism of AR is based on lymphocytes Th-2 reaction and connected with that cascade of effects. Biological treatment in the form of monoclonal antibodies blocks interleukins or immunoglobulin E signaling and leads to decrease in inflammatory reaction. Mechanism of action of these drugs and short period of use in AR requires patients to meet the including criteria and is usually used after other treatment options have run out. Taking under consideration the amount of patients suffering from AR and the impact on the quality of life indicates that there is still a need for new drugs and using drugs which are useful in similar diseases. Purpose of the work: This study aims to review and evaluate biological drugs used or having the potential to be used in the treatment of allergic rhinitis (AR), including: omalizumab, dupilumab, mepolizumab, reslizumab and the possibility of their use on a wider scale in the future. Materials and methods: An analysis of research papers available on PubMed and Google Scholar was undertaken using the following keywords: chronic rhinitis with nasal polyps; immunotherapy; monoclonal antibodies; allergic rhinitis; Quality of Life in rhinitis; omalizumab; dupilumab; mepolizumab; reslizumab; biological treatment during pregnancy; Results: The use of biological drugs in AR results in a significant improvement in symptom control and an increase in quality of life. This option can be an effective form of treatment for nasal polyps, reducing the risk of needing sinus surgery. However, the criteria for using these drugs are still very limiting, due to the lack of specific biomarkers that could early indicate a high chance of success. Biological drugs seem to be a great opportunity and a worthwhile possibility in the treatment of people with chronic allergic rhinitis.
简介慢性鼻炎的广泛流行要求人们寻找有效的治疗方法。现代医学是生物治疗。AR 的病理机制以淋巴细胞 Th-2 反应为基础，并与之相关联。以单克隆抗体为形式的生物治疗可阻断白细胞介素或免疫球蛋白 E 的信号传导，从而减轻炎症反应。这类药物的作用机制和在 AR 中的短期使用要求患者符合包括在内的标准，通常在其他治疗方案用尽后使用。考虑到 AR 患者的数量及其对生活质量的影响，仍有必要开发新药，并使用对类似疾病有用的药物。 工作目的：本研究旨在回顾和评估用于或有可能用于治疗过敏性鼻炎（AR）的生物药物，包括：奥马珠单抗、双珠单抗、美博利珠单抗、瑞舒珠单抗，以及将来在更大范围内使用这些药物的可能性。材料与方法使用以下关键词对PubMed和谷歌学术网站上的研究论文进行分析：慢性鼻炎伴鼻息肉；免疫疗法；单克隆抗体；过敏性鼻炎；鼻炎患者的生活质量；奥马珠单抗；双珠单抗；mepolizumab；reslizumab；孕期生物治疗；结果：在妊娠期鼻炎患者中使用生物制剂可显著改善症状控制，提高生活质量。这种方法可以有效治疗鼻息肉，降低需要进行鼻窦手术的风险。然而，使用这些药物的标准仍然非常有限，因为缺乏特定的生物标志物，而这些生物标志物可以及早显示成功的几率有多大。在治疗慢性过敏性鼻炎患者方面，生物药物似乎是一个很好的机会和值得考虑的可能性。
{"title":"Biological Therapy, Therapeutic Approaches and Future Perspectives in the Treatment of Chronic Rhinitis","authors":"Agata Magierska, Z. Szczepaniak, Olga Ptak, Krzysztof Gomułka","doi":"10.12775/qs.2024.18.52161","DOIUrl":"https://doi.org/10.12775/qs.2024.18.52161","url":null,"abstract":"Introduction: The widespread prevalence of chronic rhinitis necessitates the search for effective treatment methods. Modern type of medicine is biological treatment. Pathomechanism of AR is based on lymphocytes Th-2 reaction and connected with that cascade of effects. Biological treatment in the form of monoclonal antibodies blocks interleukins or immunoglobulin E signaling and leads to decrease in inflammatory reaction. Mechanism of action of these drugs and short period of use in AR requires patients to meet the including criteria and is usually used after other treatment options have run out. Taking under consideration the amount of patients suffering from AR and the impact on the quality of life indicates that there is still a need for new drugs and using drugs which are useful in similar diseases. \u0000Purpose of the work: This study aims to review and evaluate biological drugs used or having the potential to be used in the treatment of allergic rhinitis (AR), including: omalizumab, dupilumab, mepolizumab, reslizumab and the possibility of their use on a wider scale in the future. \u0000Materials and methods: An analysis of research papers available on PubMed and Google Scholar was undertaken using the following keywords: chronic rhinitis with nasal polyps; immunotherapy; monoclonal antibodies; allergic rhinitis; Quality of Life in rhinitis; omalizumab; dupilumab; mepolizumab; reslizumab; biological treatment during pregnancy; \u0000Results: The use of biological drugs in AR results in a significant improvement in symptom control and an increase in quality of life. This option can be an effective form of treatment for nasal polyps, reducing the risk of needing sinus surgery. However, the criteria for using these drugs are still very limiting, due to the lack of specific biomarkers that could early indicate a high chance of success. Biological drugs seem to be a great opportunity and a worthwhile possibility in the treatment of people with chronic allergic rhinitis.","PeriodicalId":431915,"journal":{"name":"Quality in Sport","volume":"30 17","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141803100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-25DOI: 10.12775/qs.2024.18.53225
Katarzyna Ciuba, Barbara Borodziuk, Filip Borodziuk, Paulina Dąbrowska, Michał Żuber, Karol Bochyński, Katarzyna Molenda, Michał Dacka, Kamila Giżewska, Konrad Białogłowski
Severe headaches or migraines are a common neurological disorder that can significantly affect people's daily lives and is serious problem for individuals and society. A migraine is intense headache lasting 4-72 hours, typically localized on one side of the head and accompanied by nausea, sensitivity to light (phonophobia), sound (photophobia), and smell (osmophobia). The pathophysiology of migraines is complex and involves neurovascular and biochemicals mechanisms. Understanding the mechanisms that trigger the transition from a headache-free state to the headache phase is important to understand the underlying causes of migraine attacks and developing effective treatment methods. Caffeine can have both positive and negative influence on individuals suffering from migraine. It is use as adjuvant component in migraine treatment, but it can also act as a trigger for migraines. The therapeutic mechanisms of caffeine in migraine headaches are multidirectional and include: vascular effects, modulation of NO production, adenosine antagonism, potential interactions with the gut-brain axis and inhibition of leukotrienes and prostaglandins’ synthesis. On the other hand, the onset of migraine attack may be related to caffeine consumption or withdrawal. The purpose of this study is to review and systematize the available data about relation caffeine use to migraine.
{"title":"Caffeine and migraine – friends or enemies?","authors":"Katarzyna Ciuba, Barbara Borodziuk, Filip Borodziuk, Paulina Dąbrowska, Michał Żuber, Karol Bochyński, Katarzyna Molenda, Michał Dacka, Kamila Giżewska, Konrad Białogłowski","doi":"10.12775/qs.2024.18.53225","DOIUrl":"https://doi.org/10.12775/qs.2024.18.53225","url":null,"abstract":"Severe headaches or migraines are a common neurological disorder that can significantly affect people's daily lives and is serious problem for individuals and society. A migraine is intense headache lasting 4-72 hours, typically localized on one side of the head and accompanied by nausea, sensitivity to light (phonophobia), sound (photophobia), and smell (osmophobia). The pathophysiology of migraines is complex and involves neurovascular and biochemicals mechanisms. Understanding the mechanisms that trigger the transition from a headache-free state to the headache phase is important to understand the underlying causes of migraine attacks and developing effective treatment methods. Caffeine can have both positive and negative influence on individuals suffering from migraine. It is use as adjuvant component in migraine treatment, but it can also act as a trigger for migraines. The therapeutic mechanisms of caffeine in migraine headaches are multidirectional and include: vascular effects, modulation of NO production, adenosine antagonism, potential interactions with the gut-brain axis and inhibition of leukotrienes and prostaglandins’ synthesis. On the other hand, the onset of migraine attack may be related to caffeine consumption or withdrawal. The purpose of this study is to review and systematize the available data about relation caffeine use to migraine.","PeriodicalId":431915,"journal":{"name":"Quality in Sport","volume":"21 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141803474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-24DOI: 10.12775/qs.2024.18.53253
Katarzyna Chawrylak, Maria Kubas, Katarzyna Krzemińska, Julia Kuszneruk, Magdalena Kłusek
Introduction and Purpose: Guidelines recommend at least 150 minutes of moderate-intensity aerobic activity weekly for postpartum women to enhance cardiovascular fitness, muscle strength, weight management, and mental health, particularly in alleviating postpartum depression (PPD). This review aimed to overview physical activity (PA) in postpartum women and identify key aspects to improve their health and quality of life. Methods: A literature review was conducted using PubMed and Google Scholar, focusing on articles from 2015 to 2024, including observational studies, clinical trials, meta-analyses, and systematic reviews. Non-English articles and book chapters were excluded. State of Knowledge: Studies highlighted the effectiveness of various exercise regimens for postpartum conditions. Trunk stabilization exercises significantly reduced lumbopelvic pain and disability. Exercise training impacted maternal vascular health and blood pressure, with regular exercise reducing blood pressure, preventing long-term cardiovascular diseases. Innovative approaches, such as progressive muscle relaxation exercises (PMRE) combined with online health counseling, reduced PPD and enhanced maternal attachment. Smartphone app-based pelvic floor muscle training (PFMT) reminders increased adherence and improved short-term pelvic floor muscle (PFM) function, showing potential long-term benefits. Summary: This review provides strong evidence for structured PA programs in postpartum care, offering benefits from pain reduction and improved cardiovascular health to enhanced mental well-being. Future research should identify barriers to PA adherence and develop tailored interventions for postpartum women.
{"title":"Physical activity during postpartum period - an analysis of the latest studies and guidelines","authors":"Katarzyna Chawrylak, Maria Kubas, Katarzyna Krzemińska, Julia Kuszneruk, Magdalena Kłusek","doi":"10.12775/qs.2024.18.53253","DOIUrl":"https://doi.org/10.12775/qs.2024.18.53253","url":null,"abstract":"Introduction and Purpose: \u0000Guidelines recommend at least 150 minutes of moderate-intensity aerobic activity weekly for postpartum women to enhance cardiovascular fitness, muscle strength, weight management, and mental health, particularly in alleviating postpartum depression (PPD). This review aimed to overview physical activity (PA) in postpartum women and identify key aspects to improve their health and quality of life. \u0000 \u0000Methods: \u0000A literature review was conducted using PubMed and Google Scholar, focusing on articles from 2015 to 2024, including observational studies, clinical trials, meta-analyses, and systematic reviews. Non-English articles and book chapters were excluded. \u0000 \u0000State of Knowledge: \u0000Studies highlighted the effectiveness of various exercise regimens for postpartum conditions. Trunk stabilization exercises significantly reduced lumbopelvic pain and disability. Exercise training impacted maternal vascular health and blood pressure, with regular exercise reducing blood pressure, preventing long-term cardiovascular diseases. Innovative approaches, such as progressive muscle relaxation exercises (PMRE) combined with online health counseling, reduced PPD and enhanced maternal attachment. Smartphone app-based pelvic floor muscle training (PFMT) reminders increased adherence and improved short-term pelvic floor muscle (PFM) function, showing potential long-term benefits. \u0000 \u0000Summary: \u0000This review provides strong evidence for structured PA programs in postpartum care, offering benefits from pain reduction and improved cardiovascular health to enhanced mental well-being. Future research should identify barriers to PA adherence and develop tailored interventions for postpartum women.","PeriodicalId":431915,"journal":{"name":"Quality in Sport","volume":"47 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141807104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-24DOI: 10.12775/qs.2024.17.53018
Weronika Kmiotek, Radosław Oronowicz, Gabriela Różańska-Smuszkiewicz, Paweł Smuszkiewicz-Różański, Aleksandra Karuś, Grzegorz Jama, Paweł Staszczak, Barbara Jaworska, Dagmara Ragan
Introduction and Purpose: We are increasingly seeing new trends on social media regarding intense strength training in pregnant women. How much should women in a physiological pregnancy exercise? The aim of this piece is to trace the guidelines and set a healthy limit for such an important aspect during pregnancy. Materials and methods: A literature search was conducted using the medical databases PubMed and Google Scholar. Articles were retrieved in English, employing the key words: “strength training”, “activity during pregnancy”, „intensive exercise” and „ physical activity guidelines” appropriate configurations. Conclusions: The available guidelines and medical literature show that it is worthwhile to regularly practise sport both during and in preparation for pregnancy. In a healthy, physiological pregnancy, there is a wide range of activities to choose from, through which health benefits can be achieved, such as strengthening muscles, improving performance, alleviating pregnancy complaints (constipation, pain, nausea) and improving wellbeing, and much more. However, there are contraindications to certain exercises for specific conditions during pregnancy. You should consult your doctor on a case-by-case basis.
简介和目的：我们越来越多地在社交媒体上看到关于孕妇进行高强度力量训练的新趋势。处于生理妊娠期的妇女应该做多少运动？本文旨在追溯指导方针，并为孕期这一重要方面设定一个健康的限度：使用医学数据库 PubMed 和 Google Scholar 进行文献检索。检索的文章均为英文，并使用了以下关键词："力量训练"、"孕期活动"："结论：现有的指南和医学文献表明，在孕期和备孕期间定期进行体育锻炼是值得的。在健康的生理妊娠期，有多种活动可供选择，通过这些活动可以达到有益健康的目的，如增强肌肉力量、提高成绩、缓解妊娠反应（便秘、疼痛、恶心）、改善身心健康等等。不过，在怀孕期间，某些特定情况下的运动是有禁忌的。您应根据具体情况咨询医生。
{"title":"Effects of intense exercise on pregnancy - a review of the literature","authors":"Weronika Kmiotek, Radosław Oronowicz, Gabriela Różańska-Smuszkiewicz, Paweł Smuszkiewicz-Różański, Aleksandra Karuś, Grzegorz Jama, Paweł Staszczak, Barbara Jaworska, Dagmara Ragan","doi":"10.12775/qs.2024.17.53018","DOIUrl":"https://doi.org/10.12775/qs.2024.17.53018","url":null,"abstract":"Introduction and Purpose: We are increasingly seeing new trends on social media regarding intense strength training in pregnant women. How much should women in a physiological pregnancy exercise? The aim of this piece is to trace the guidelines and set a healthy limit for such an important aspect during pregnancy.\u0000Materials and methods: A literature search was conducted using the medical databases PubMed and Google Scholar. Articles were retrieved in English, employing the key words: “strength training”, “activity during pregnancy”, „intensive exercise” and „ physical activity guidelines” appropriate configurations.\u0000Conclusions: The available guidelines and medical literature show that it is worthwhile to regularly practise sport both during and in preparation for pregnancy. In a healthy, physiological pregnancy, there is a wide range of activities to choose from, through which health benefits can be achieved, such as strengthening muscles, improving performance, alleviating pregnancy complaints (constipation, pain, nausea) and improving wellbeing, and much more. However, there are contraindications to certain exercises for specific conditions during pregnancy. You should consult your doctor on a case-by-case basis.","PeriodicalId":431915,"journal":{"name":"Quality in Sport","volume":"41 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141807625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-24DOI: 10.12775/qs.2024.18.53224
Monika Szyszka, Adrian Kruszewski, Maja Kucharska, Anna Dąbrowska, Karolina Błaszczak, Natalia Paduszyńska, Paulina Przybysz
ABSTRACT: Prolactinoma is a benign tumor of the pituitary gland that leads to the overproduction of prolactin. It is the most common type of pituitary adenoma, accounting for approximately 50% of all pituitary tumors. The clinical presentation of prolactinoma varies depending on the level of prolactin elevation and the size of the tumor. In women, common symptoms include galactorrhea, amenorrhea, and infertility. Men may present with hypogonadism, decreased libido, erectile dysfunction, and gynecomastia. Large prolactinomas, known as macroadenomas, can cause mass effects such as headaches, visual disturbances due to compression of the optic chiasm, and hypopituitarism due to pressure on surrounding pituitary tissue. Understanding the pathogenesis of prolactinoma is crucial for developing effective treatments and improving patient outcomes. The development of prolactinomas involves a complex interplay of genetic, hormonal, and cellular factors. Treatment of prolactinoma aims to normalize prolactin levels, reduce tumor size, and alleviate symptoms. The first-line therapy is dopamine agonists, such as cabergoline and bromocriptine, with surgery and radiotherapy reserved for refractory cases. Furthermore, chemotherapeutic agent - temozolomide may be a treatment of choice in aggressive or malignant prolactinomas. By understanding the underlying mechanisms and different treatment methods, healthcare providers can optimize the management and outcomes for patients with prolactinoma.
{"title":"Pathogenesis, diagnosis and current treatment of prolactinoma: a review of the literature","authors":"Monika Szyszka, Adrian Kruszewski, Maja Kucharska, Anna Dąbrowska, Karolina Błaszczak, Natalia Paduszyńska, Paulina Przybysz","doi":"10.12775/qs.2024.18.53224","DOIUrl":"https://doi.org/10.12775/qs.2024.18.53224","url":null,"abstract":"ABSTRACT: \u0000Prolactinoma is a benign tumor of the pituitary gland that leads to the overproduction of prolactin. It is the most common type of pituitary adenoma, accounting for approximately 50% of all pituitary tumors. The clinical presentation of prolactinoma varies depending on the level of prolactin elevation and the size of the tumor. In women, common symptoms include galactorrhea, amenorrhea, and infertility. Men may present with hypogonadism, decreased libido, erectile dysfunction, and gynecomastia. Large prolactinomas, known as macroadenomas, can cause mass effects such as headaches, visual disturbances due to compression of the optic chiasm, and hypopituitarism due to pressure on surrounding pituitary tissue. Understanding the pathogenesis of prolactinoma is crucial for developing effective treatments and improving patient outcomes. The development of prolactinomas involves a complex interplay of genetic, hormonal, and cellular factors. Treatment of prolactinoma aims to normalize prolactin levels, reduce tumor size, and alleviate symptoms. The first-line therapy is dopamine agonists, such as cabergoline and bromocriptine, with surgery and radiotherapy reserved for refractory cases. Furthermore, chemotherapeutic agent - temozolomide may be a treatment of choice in aggressive or malignant prolactinomas. By understanding the underlying mechanisms and different treatment methods, healthcare providers can optimize the management and outcomes for patients with prolactinoma.","PeriodicalId":431915,"journal":{"name":"Quality in Sport","volume":"35 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141809059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-23DOI: 10.12775/qs.2024.17.53023
Adrian Kruszewski, Anna Dąbrowska, Paulina Przybysz, Maja Kucharska, Monika Szyszka, Natalia Paduszyńska, Karolina Błaszczak
Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) was previously known as non-alcoholic fatty liver disease (NAFLD). MASLD is one of the most important and leading causes of liver disease worldwide. This disease is a public health challenge in the 21st century. Aim of the study: This article aims to present the latest literature data on MASLD. The study is intended to show what consequences are associated with changing the name of the disease and this article is purposive to be a vademecum of knowledge for practicing physicians. Material and methods: Comprehensive literature searches were performed across the main electronic databases of PubMed and GoogleScholar using the keywords: "metabolic-dysfunction associated steatotic liver disease”, “MASLD”, “non-alcoholic fatty liver disease” and “NAFLD” Conclusions: Most patients do not report any symptoms. It is important to identify patients at increased risk of MASLD. A fundamental role in prevention and treatment is lifestyle changes. The pharmacological approach includes among others use of antidiabetic drugs and treatment of other associated states.
{"title":"A new name for an old problem. Metabolic dysfunction-associated steatotic liver disease - review of literature","authors":"Adrian Kruszewski, Anna Dąbrowska, Paulina Przybysz, Maja Kucharska, Monika Szyszka, Natalia Paduszyńska, Karolina Błaszczak","doi":"10.12775/qs.2024.17.53023","DOIUrl":"https://doi.org/10.12775/qs.2024.17.53023","url":null,"abstract":"Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) was previously known as non-alcoholic fatty liver disease (NAFLD). MASLD is one of the most important and leading causes of liver disease worldwide. This disease is a public health challenge in the 21st century. \u0000Aim of the study: This article aims to present the latest literature data on MASLD. The study is intended to show what consequences are associated with changing the name of the disease and this article is purposive to be a vademecum of knowledge for practicing physicians. \u0000Material and methods: Comprehensive literature searches were performed across the main electronic databases of PubMed and GoogleScholar using the keywords: \"metabolic-dysfunction associated steatotic liver disease”, “MASLD”, “non-alcoholic fatty liver disease” and “NAFLD” \u0000Conclusions: Most patients do not report any symptoms. It is important to identify patients at increased risk of MASLD. A fundamental role in prevention and treatment is lifestyle changes. The pharmacological approach includes among others use of antidiabetic drugs and treatment of other associated states.","PeriodicalId":431915,"journal":{"name":"Quality in Sport","volume":"71 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141810413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：